Nama Insights

Avalyn Pharma (AVLN)

Healthcare · Biotechnology · NASDAQ

Avalyn Pharma (AVLN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.28B and a free-cash-flow yield of -6.8%. Nama's AI scorecard rates it Sell, 3.2 out of 10.
AI scorecard
Sell · 3.2/10
Negative, at the mild end of Sell. As of Nov 20, 2026.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-29.3%
How far the last close sits under the highest price of the past five years.
Market cap$1.28B
Trailing P/E—
Price / book3.2
Price / sales—
FCF yield-6.8%
Dividend yield—
Gross margin0.0%
Operating margin0.0%
Net margin0.0%
Revenue growth (YoY)—
Revenue growth (3-yr annual)—
EPS growth (YoY)—
FCF/share growth (YoY)—
Beta—
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology

AVLN earnings

Next report: Mar 18, 2027 (Q4 2026, EPS estimate -$0.72). Beat the EPS estimate in 1 of 3 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Nov 12, 2026 -$0.67 -$0.75 +10.7% $0
Q2 2026 Aug 12, 2026 -$0.98 -$0.56 -75.0% $0
Q1 2026 Jun 3, 2026 -$21.83 -$0.81 -2595.1% $0

AVLN analyst price target

Median target $60.00 from 5 analysts, ranging $52.00 – $80.00.

Biotechnology peers

TickerCompanyMarket capP/E
VRTX Vertex Pharmaceuticals $132.01B 27.4
REGN Regeneron Pharmaceuticals $95.52B 16.7
MRNA Moderna $80.65B —
ARGX argenx $59.24B 32.9
ONC BeOne Medicines $45.66B 50.8
RPRX Royalty Pharma $38.94B 12.8
RVMD Revolution Medicines $34.48B —
INSM Insmed $31.69B —
Explore live AVLN data on Nama Insights →

AVLN FAQ

Is AVLN a buy?
Nama's AI scorecard currently rates Avalyn Pharma Sell (3.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
When does AVLN report earnings?
Avalyn Pharma's next scheduled report is on Mar 18, 2027. Analysts expect EPS of -$0.72.
What is the AVLN price target?
The median analyst price target from 5 analysts is $60.00, with a range of $52.00 – $80.00.
Is AVLN Shariah compliant?
Nama's AAOIFI-style screen reads Avalyn Pharma as Can't Tell. A figure the screen needs is missing, so it can't tell.